SCHEMBL6974955

SCHEMBL6974955

C=CC1CCCCC(=O)N1C(=O)OC(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
ELANE P08246 1/20 0.36
EPHX1 P07099 1/20 0.35
HPGD P15428 1/20 0.34
DDB1 Q16531 2/20 0.33
CRBN Q96SW2 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
ATM Q13315 2/20 0.32
PARP1 P09874 1/20 0.32
PREP P48147 1/20 0.32
RIPK1 Q13546 1/20 0.32
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
GPR119 Q8TDV5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19420055 0.90 CHRM2 (0.40) CHRM2CHRM1CHRM3ELANEHPGD
SCHEMBL11027710 0.90 CHRM2 (0.40) CHRM2CHRM1CHRM3ELANEHPGD
SCHEMBL6969595 0.87 DDB1 (0.38) CHRM2CHRM1CHRM3ELANEEPHX1
SCHEMBL6979848 0.83 ATM (0.37) CHRM2CHRM1CHRM3ELANEEPHX1
SCHEMBL6972167 0.76 ATM (0.38) CHRM2CHRM1CHRM3ELANEEPHX1
SCHEMBL24366649 0.75 CHRM2 (0.41) CHRM2CHRM1CHRM3ELANEEPHX1
SCHEMBL15017885 0.75 CHRM2 (0.41) CHRM2CHRM1CHRM3ELANEEPHX1
SCHEMBL31148623 0.74 HSD17B10 (0.44) EPHX1HPGDPREPNPC1
SCHEMBL17770867 0.74 HSD17B10 (0.44) EPHX1HPGDPREPNPC1
SCHEMBL2689039 0.74 HSD17B10 (0.44) EPHX1HPGDPREPNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0821674-B1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2003-08-06 EP disclosed
US-6043261-A TREATMENT OF INFLAMMATORY CONDITIONS AFFECTING THE JOINTS, FOR EXAMPLE ARTHRITIS, INFLAMMATORY BOWEL DISEASE, CARDIOVASCULAR ISCHEMIA, DIABETES, HYPERALGESIA, CEREBRAL ISCHEMIA, THROMBOTIC STROKE, GLOBAL ISCHEMIA, NERVOUS SYSTEM DISORDERS G. D. SEARLE & CO. (US) 2000-03-28 US disclosed
US-6011028-A Cyclic amidino agents useful as nitric oxide synthase inhibitors G.D. SEARLE & CO. (US) 2000-01-04 US disclosed
US-5883251-A ENZYME INHIBITORS G. D. SEARLE & CO. (US) 1999-03-16 US disclosed
EP-0821674-A1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1998-02-04 EP disclosed
WO-1996033175-A1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1996-10-24 WO disclosed